20 Folgen
ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum American Society of Retina Specialists (ASRS)
-
- Gesundheit und Fitness
Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS) offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief for JVRD as he discusses cutting-edge developments featured in JVRD with the lead authors who share clinical pearls and explore their significance for advancing patient care. Audio episodes are available on Amazon Music, Apple Podcasts, Google Podcasts, Spotify and other podcast directories. Or visit our YouTube channel to watch the dynamic conversation in each episode.
-
Ophthalmologic Presentations of Incontinentia Pigmenti
On this episode of the JVRD Author's Forum, Dr. Timothy Murray joins Philip J. Ferrone, MD, FASRS, to discuss a JVRD case report from the March/April 2024 issue updating our understanding of treatments and outcomes in 36 eyes of 18 patients with incontinentia pigmenti. For more information visit www.ASRS.org/JVRDForum.Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (A...
-
Outcomes of PPV With Membrane Peel for Lamellar Macular Holes Using a New OCT Consensus Definition
On this episode of the JVRD Author's Forum, Dr. Timothy Murray joins John T. Thompson, MD, Associate Editor-in-Chief, to discuss a JVRD article from the March/April 2024 issue on the updated application of the 2020 spectral-domain optical coherence tomography (SD-OCT) consensus to the preoperative classification of macular hole and other macular pathologies to determine whether SD-OCT classification can be useful in determining visual outcomes. For more information visit www.ASRS.org/JVR...
-
Gene Expression Profile Class Change in a Case of Aggressive, Recurrent Melanoma
In this episode, Dr. Timothy Murray joins Dr. Jennifer Aye to talk about a case of recurrent aggressive ciliochoroidal melanoma requiring enucleation after brachytherapy elsewhere for recurrence at the biopsy site. The tumor showed progression from gene expression profiling (GEP) class 1A, PRAME negative to GEP Class 1b. For more information visit www.ASRS.org/JVRDForum.Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewe...
-
Chronic Effects of e-Cigarette Aerosol Inhalation on Macular Perfusion
In this episode, Dr. Timothy Murray joins Dr. Lejla Vajzovic to discuss the impact of e-cigarette use on macular perfusion employing optical coherence tomography angiography (OCTA) in a study of 25 patients. Learn if there are differences in retinal microvasculature measurements in patients using e-cigarettes compared to nonsmoker control groups.For more information visit www.ASRS.org/JVRDForum.Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the offici...
-
Retinopathy Associated With Ritonavir Treatment for HIV Infection: A Case Series Reappraisal in the COVID-19 Era
In this episode, Dr. Timothy Murray welcomes Steven Yeh, MD, University of Nebraska Medical Center, Truhlsen Eye Institute to discuss 3 cases of retinopathy secondary to ritonavir use in the treatment of HIV. The review identified 3 patients with a history of HIV treated with antiretroviral therapy including ritonavir who had been evaluated for bilateral vision loss in both eyes. Explore why ritonavir toxicity should be considered in the differential diagnosis of retinopathy among...
-
Retinal Vasculitis After Intravitreal Pegcetacoplan: Report From the ASRS ReST Committee
On this episode, Dr. Murray welcomes Andre Witkin, MD, Associate Professor, Tufts University School of Medicine, Boston, MA, to discuss the article, Retinal Vasculitis After Intravitreal Pegcetacoplan: Report From the ASRS Research and Safety in Therapeutics (ReST) Committee.On February 17, 2023, pegcetacoplan 15mg (Syfovre – Apellis Pharmaceuticals, Waltham MA) was approved by the US Food and Drug Administration (FDA) to treat geographic atrophy (GA) secondary to age-related macular degenera...
Top‑Podcasts in Gesundheit und Fitness